Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease
- 1 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 36 (9) , 821-826
Abstract
Background: Resistance to intravenous immunoglobulin (IVIG) therapy is a risk factor for coronary lesions in patients with Kawasaki disease (KD). Risk-adjusted initial therapy may improve coronary outcome in KD, but identification of high risk patients remains a challenge. This study aimed to develop a new risk assessment tool for IVIG resistance using advanced statistical techniques. Methods: Data were retrospectively collected from KD patients receiving IVIG therapy, including demographic characteristics, signs and symptoms of KD and laboratory results. A random forest (RF) classifier, a tree-based machine learning technique, was applied to these data. The correlation between each variable and risk of IVIG resistance was estimated. Results: Data were obtained from 767 patients with KD, including 170 (22.1%) who were refractory to initial IVIG therapy. The predictive tool based on the RF algorithm had an area under the receiver operating characteristic curve of 0.916, a sensitivity of 79.7% and a specificity of 87.3%. Its misclassification rate in the general patient population was estimated to be 15.5%. RF also identified markers related to IVIG resistance such as abnormal liver markers and percentage neutrophils, displaying relationships between these markers and predicted risk. Conclusions: The RF classifier reliably identified KD patients at high risk for IVIG resistance, presenting clinical markers relevant to treatment failure. Evaluation in other patient populations is required to determine whether this risk assessment tool relying on RF has clinical value.Keywords
This publication has 28 references indexed in Scilit:
- Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different EthnicitiesAmerican Journal of Therapeutics, 2016
- The epidemiology of Kawasaki disease: a global updateArchives of Disease in Childhood, 2015
- Kawasaki disease: insights into pathogenesis and approaches to treatmentNature Reviews Rheumatology, 2015
- Rapid, Accurate, and On-Site Detection of C. difficile in Stool SamplesAmerican Journal of Gastroenterology, 2015
- Molecular and immunological biomarkers to predict IVIg responseTrends in Molecular Medicine, 2015
- Predicting IVIG resistance in UK Kawasaki diseaseArchives of Disease in Childhood, 2015
- Management of Kawasaki diseaseArchives of Disease in Childhood, 2013
- Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trialThe Lancet, 2012
- Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized TrialPediatrics, 2012
- Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin ResistanceThe Journal of Pediatrics, 2011